首页> 外文学位 >Pharmacological and Clinical Factors Associated with Thrombosis in Pediatric Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass.
【24h】

Pharmacological and Clinical Factors Associated with Thrombosis in Pediatric Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass.

机译:小儿接受心肺旁路心脏手术的患者中与血栓形成相关的药理和临床因素。

获取原文
获取原文并翻译 | 示例

摘要

Postoperative thrombosis in children undergoing cardiac surgery with cardiopulmonary bypass (CPB) is a frequent, under-diagnosed and clinically detrimental complication. The majority of known risk factors for thrombosis in this context are non-modifiable clinical correlates (notably younger age at surgery and cyanosis). We sought to identify modifiable physiological risk factors for post-operative thrombosis after pediatric cardiac surgery to inform the development of thromboprophylaxis strategies.;Pediatric patients were prospectively enrolled before cardiac surgery with CPB in an observational cohort study. Children <1 year old and cyanotic patients were oversampled, and all subjects had comprehensive serial laboratory assessment of hemostatic status and standardized vascular ultrasound for surveillance of post-operative thrombosis. Of 250 enrolled patients (248 completed study, 55% <1 year old, 25% cyanotic), post-operative thrombosis was diagnosed in 64 (26%) vs. 10% in 755 control patients (p<0.001). Clinical evaluation alone missed 59% of all post-operative thrombi and 20% of clinically significant thrombi.;Preoperatively, children with heart disease had important hematological abnormalities resulting in cellular activation, a balanced coagulopathy and an altered response to heparin, the primary thromboprophylaxis agent used during CPB. While these abnormalities were associated with developmental immaturity of the coagulation system to some extent, they were also exacerbated by a higher degree of cardiac insufficiency, congestive hepatopathy and inflammation. We found large between-patient differences in response to heparin, which were not accommodated by current clinical protocols. This left a substantial proportion of patients improperly anticoagulated during CPB, resulting in an inability to attenuate the severe physiological response to CPB characterized by hemodilution, inflammatory cytokine release, leukocyte and platelet activation, and thrombin generation. Multivariable factors associated with post-operative thrombosis in these patients included worsened cardiac insufficiency in the pre- and postoperative period. However, blood antithrombin levels, individual response to heparin, intraoperative anticoagulation activity, as well as heparin and protamine management were the critical factors associated with post-operative thrombosis.;In summary, children undergoing cardiac surgery with CPB are at a substantial risk of post-operative thrombosis, and current reliance on clinical evaluation is inefficient in preventing and identifying those thrombi. Many classical clinical risk factors for postoperative thrombosis can be translated into physiological risk factors amenable to thromboprophylaxis strategies which should be individualized according to both preoperative clinical factors and heparin sensitivity.
机译:接受心脏体外循环(CPB)进行心脏手术的儿童的术后血栓形成是一种常见的,诊断不足且对临床有害的并发症。在这种情况下,大多数已知的血栓形成危险因素是不可改变的临床相关因素(尤其是手术时较年轻的年龄和发osis)。我们试图确定小儿心脏外科手术后血栓形成的可改变的生理危险因素,以指导血栓预防策略的发展。在一项观察性队列研究中,对儿童患者进行了CPB心脏外科手术前瞻性研究。对<1岁的儿童和紫cyan患者进行了过度采样,所有受试者均进行了全面的止血状态连续实验室评估和标准化的血管超声检查,以监测术后血栓形成。在250名入组患者(248名完成的研究,55%<1岁,发otic的25%)中,有64名(26%)诊断为术后血栓形成,而755名对照患者为10​​%(p <0.001)。单独的临床评估漏掉了所有术后血栓的59%和临床上显着的血栓的20%。术前,患有心脏病的儿童有重要的血液学异常,导致细胞活化,平衡性凝血病和对主要血栓预防药物肝素的反应改变。在CPB中使用。尽管这些异常在一定程度上与凝血系统的发育不成熟有关,但由于心脏功能不全,充血性肝病和炎症程度更高,这些异常也加剧了。我们发现患者之间对肝素的反应存在很大差异,而当前的临床方案并未解决这些差异。这使得相当一部分患者在CPB期间无法正确抗凝,导致无法减弱对CPB的严重生理反应,其特征在于血液稀释,炎性细胞因子释放,白细胞和血小板活化以及凝血酶生成。这些患者与术后血栓形成相关的多因素包括术前和术后心脏功能不全加重。然而,血液中抗凝血酶水平,对肝素的个体反应,术中抗凝活性以及肝素和鱼精蛋白管理是与术后血栓形成相关的关键因素。总之,接受CPB心脏手术的儿童发生术后血栓的风险很高。术中血栓形成,目前依靠临床评估无法有效预防和识别血栓。术后血栓形成的许多经典临床危险因素都可以转化为适合血栓预防策略的生理危险因素,应根据术前临床因素和肝素敏感性将其个体化。

著录项

  • 作者

    Manlhiot, Cedric.;

  • 作者单位

    University of Toronto (Canada).;

  • 授予单位 University of Toronto (Canada).;
  • 学科 Medicine.
  • 学位 Ph.D.
  • 年度 2015
  • 页码 236 p.
  • 总页数 236
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号